Biofil Chemicals & Pharmaceuticals Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Pharma Unit: 66.8% • Chemicals Div.: 33.2%
AI Sector View
AI GENERATEDOil Gas & Consumable Fuels
Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.
PROS
- Company comfortably covers its interest (342.5x coverage)
- Company generates healthy free cash flow
- Company maintains a comfortable, low leverage position
CONS
- Recent results are weak - TTM profit is down 90.8% versus prior year
- A large part of profit comes from other income (89.4% of PBT)
- Operating cash flow has been negative in recent years
- Company has a low return on capital employed of 8.3%
- Company has a low return on equity of 6.9% over last 3 years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.03x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADANIENT | 2936.00 | 53.39 | 397452.96 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| PREMIERENE | 998.00 | 27.21 | 45304.36 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 33.72 | 29.03 |
| AEGISLOG | 1270.55 | 35.64 | 44596.31 | 0.68 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| CPPLUS | 3705.90 | 91.86 | 43840.96 | 0.04 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| REDINGTON | 371.40 | 17.07 | 29035.10 | 1.62 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| HONASA | 470.75 | 61.67 | 15347.59 | 0.64 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| LLOYDSENT | 74.20 | 100.87 | 11327.02 | 0.20 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| SGMART | 826.10 | 83.74 | 10411.77 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 10.43 | 4.49 |
| MMTC | 64.18 | 21.52 | 9627.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 33.46 | -1423.53 |
| ENTERO | 1827.20 | 63.41 | 7952.54 | 0.00 | 52.05 | 72.17 | 1940.50 | 38.23 | 10.93 | 5.00 |
| CELLO | 342.50 | 24.69 | 7724.69 | 0.44 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| BIOFILCHEM | 31.70 | 107.03 | 51.59 | 0.00 | 0.11 | -95.48 | 12.35 | 92.07 | 15.78 | 1.13 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 17 | 5 | 15 | 8 | 2 | 14 | 8 | 6 | 14 | 1 | 8 | 12 | |
| 2 | 17 | 5 | 15 | 8 | 2 | 14 | 8 | 6 | 13 | 1 | 7 | 12 | |
| Operating Profit | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OPM % | 16.87% | 1.38% | 3.78% | -0.26% | 3.55% | 4.98% | 2.18% | 1.32% | 0.00% | 0.81% | 11.63% | 5.81% | 0.57% |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| Tax % | 25.00% | 20.00% | 18.18% | 11.11% | 26.09% | 33.33% | 27.27% | 20.00% | 12.68% | 27.27% | 27.27% | 55.32% | 18.66% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| 0.15 | 0.08 | 0.06 | 0.15 | 0.10 | 0.01 | 0.10 | 0.12 | 1.48 | 0.05 | 0.05 | 0.13 | 0.07 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 | 12 | 23 | 30 | 36 | 22 | 30 | 40 | 33 | 28 | 34 | |
| 11 | 11 | 22 | 28 | 34 | 21 | 29 | 39 | 33 | 28 | 34 | |
| Operating Profit | 3 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| OPM % | 19.48% | 7.57% | 4.43% | 6.14% | 4.47% | 5.95% | 3.89% | 2.04% | 2.54% | 2.29% | 2.10% |
| 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 3 | 1 |
| Tax % | 22.34% | 19.98% | 19.39% | 17.55% | 35.31% | 31.19% | 29.33% | 18.04% | 24.24% | 19.24% | 41.87% |
| Net Profit | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 0 |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 0.44 | 0.34 | 0.44 | 0.34 | 1.71 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 8%
- 5 Years:
- -5%
- 3 Years:
- -2%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 14%
- 5 Years:
- 18%
- 3 Years:
- 71%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -13%
- 3 Years:
- -14%
- 1 Year:
- -26%
RETURN ON EQUITY
- 10 Years:
- 7%
- 5 Years:
- 6%
- 3 Years:
- 7%
- Last Year:
- 14%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| -4 | -3 | -3 | -1 | -0 | 1 | 1 | 2 | 3 | 5 | |
| 1 | 2 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 3 | |
| Trade Payables | 7 | 9 | 9 | 26 | 16 | 1 | 13 | 28 | 31 | 17 |
| 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Total Liabilities | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 47 | 51 | 43 |
| 9 | 9 | 10 | 10 | 10 | 9 | 9 | 9 | 8 | 7 | |
| 0 | 1 | 1 | 2 | 4 | 1 | 1 | 3 | 3 | 4 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 38 | 28 | |
| Cash & Bank | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 3 |
| 12 | 14 | 13 | 30 | 19 | 8 | 21 | 1 | 1 | 1 | |
| Total Assets | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 47 | 51 | 43 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 1 | 1 | 2 | 0 | 0 | 2 | -2 | -1 | |
| Cash from Investing | -0 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | 1 |
| Cash from Financing | -0 | -0 | -0 | -1 | -1 | -0 | 0 | -0 | -0 | 3 |
| 0 | 0 | -0 | 0 | 0 | -0 | -0 | 2 | -2 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | ||||||||||
| EPS (₹) | 1.10 | 0.29 | 0.30 | 0.74 | 0.76 | 0.43 | 0.34 | 0.44 | 0.34 | 1.71 |
| Book Value (₹) | 7.80 | 8.09 | 8.39 | 9.15 | 9.91 | 10.35 | 10.63 | 11.19 | 11.54 | 13.25 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 1.28 | 0.47 | 0.52 | 0.99 | 1.02 | 0.69 | 0.61 | 0.68 | 0.58 | 1.88 |
| PROFITABILITY | ||||||||||
| Operating Margin % | 20.50% | 8.39% | 4.86% | 6.72% | 6.71% | 6.63% | 4.21% | 2.04% | 2.54% | 2.29% |
| Net Margin % | 13.34% | 3.81% | 2.09% | 4.07% | 3.47% | 3.12% | 1.87% | 1.77% | 1.67% | 9.81% |
| ROE % | 18.09% | 3.64% | 3.60% | 8.46% | 8.01% | 4.24% | 3.28% | 4.00% | 3.02% | 13.81% |
| ROCE % | 21.86% | 5.13% | 5.06% | 10.12% | 12.18% | 6.23% | 4.76% | 4.97% | 4.08% | 15.78% |
| 7.81% | 2.05% | 1.99% | 3.63% | 3.28% | 2.69% | 2.24% | 1.81% | 1.14% | 5.94% | |
| EFFICIENCY | ||||||||||
| Debtor Days | 345 | 361 | 197 | 257 | 240 | 199 | 168 | 244 | 390 | 424 |
| Inventory Days | 4 | 18 | 17 | 18 | 31 | 46 | 15 | 17 | 32 | 47 |
| Payable Days | 401 | 303 | 162 | 249 | 235 | 154 | 88 | 196 | 346 | 338 |
| -52 | 75 | 53 | 25 | 35 | 91 | 95 | 66 | 76 | 133 | |
| FINANCIAL HEALTH | ||||||||||
| Debt to Equity (x) | 0.11x | 0.12x | 0.12x | 0.08x | 0.03x | 0.03x | 0.03x | 0.02x | 0.03x | 0.14x |
| Interest Coverage (x) | 15.12x | 4.86x | 4.70x | 12.96x | 29.18x | 26.00x | 19.66x | 21.85x | 20.95x | 342.54x |
| 1.39x | 1.36x | 1.32x | 1.17x | 1.40x | 6.23x | 1.63x | 1.35x | 1.34x | 1.73x | |
| GROWTH | ||||||||||
| Revenue Growth % | 2.15% | -8.13% | 87.12% | 28.37% | 20.41% | -37.39% | 34.19% | 33.29% | -16.57% | -14.99% |
| Operating Profit Growth % | 97.37% | -62.41% | 8.49% | 77.33% | 20.26% | -38.18% | -14.73% | 3.29% | -11.76% | 223.76% |
| Net Profit Growth % | 129.25% | -73.77% | 2.46% | 150.30% | 2.83% | -43.74% | -19.76% | 26.55% | -21.36% | 399.55% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 26.54% | -21.36% | 399.56% | |
| VALUATION | ||||||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 138.50x | 120.02x | 15.12x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.40x | 3.56x | 1.95x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 73.79x | 58.26x | 11.20x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-08-28 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30, 44 and 47 of SEBI (LODR) Regulations, 2015 and in compliance with section 108 of the Companies Act, 2013 read with rule 20 of the Companies (Management and Administration) Rules, 2014.
2026-08-26 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about about intimation of e-voting for 41st Annual General Meeting
2026-08-26 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not registered with the company/ depository participants
2026-08-26 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026
2026-08-19 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of Notice of 41st AGM through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM )
2026-08-12 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-11 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company notwithstanding attaining the age of 75 (seventy-five) years
2026-08-11 - Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-01 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
News
Recent coverage and analyst commentary for BIOFILCHEM
Loading news…
AI Stock Analyst
Biofil Chemicals & Pharmaceuticals Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account